https://www.aramis.admin.ch/Beteiligte/?ProjectID=47790&Sprache=fr-CH
Small molecule FZD7 inhibitors for Triple Negative Breast Cancer - Participants
Small molecule FZD7 inhibitors for Triple Negative Breast Cancer
triple negative breast cancersmall moleculeinhibitorsparticipants
https://www.frontiersin.org/journals/oncology/articles/10.3389/fonc.2022.925495/full
Frontiers | Antitumor effect and mechanism of FZD7 polypeptide vaccine
The resistant cells that proliferate after radiotherapy and chemotherapy are primarily tumor stem cells with high stem marker expression, and their presence ...
frontiersantitumoreffectmechanismpolypeptide
https://scholars.lib.ntu.edu.tw/entities/publication/9fe5248f-2833-45fa-8eb6-41d6ae77f2f9
Frizzled-7 (FZD7)-mediated non-canonical Wnt-Planar Cell Polarity (PCP) signalling pathway as a...
https://biosensordb.ucsd.edu/biosensorDB/bsView.php?IDin=1345
FZD7-cpGFP - FZD7 Fluorescent Biosensor Details
fluorescentbiosensordetails
https://udspace.udel.edu/items/4ce7a61d-602a-470c-add4-d0af34bee5a6
FZD7-Targeted Nanoparticles to Enhance Doxorubicin Treatment of Triple-Negative Breast Cancer
Doxorubicin (DOX) is a chemotherapy agent commonly used to treat triple-negative breast cancer (TNBC), but it has insufficient efficacy against the disease and...